| Name | Title | Contact Details |
|---|
World Congress is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. World Congress is based in Woburn, MA. You can find more information on World Congress at www.worldcongress.com
Green Tree School and Services (GTSS) is a nonprofit, state-licensed agency that provides education, therapeutic and clinical support to children ages 5-21 with Autism Spectrum Disorder and Severe Emotional Disability. GTSS only serves children whose disabilities are such that they are unable to succeed in a school- based special education program or participate in out of school activities. Rates of both diagnosis are growing, with 1 in 68 children currently affected by Autism and 1 in 78 children affected by Emotional Disability. GTSS’ philosophy is rooted in the belief that every child should have the opportunity to learn the academic, social, emotional, and vocational and life skills they need to achieve resiliency and succeed in their learning, living and working environments. GTSS has worked with children and young adults with special needs since 1957, marking over a half century of Transforming Lives and Impacting Communities. GTSS offers a variety of on-site and off-site services to children with special needs, both directly and through their home school or district. The Approved Private School educates children whose disabilities prevent them from succeeding in a traditional special education program. Specialists work with children, in small groups or individually, to help students meet individual goals. The Outpatient Clinic provides psychiatric evaluation, case management and medication management services to students at the school. Consulting Services, also called Green Tree Partnerships, is an education consulting cooperative created by GTSS. Staff work collaboratively with a school or district and take on the management of portion of that school or district’s special education program. Students who exhibit signs of autism or emotional disabilities, but do not have a complete or up to date Individual Educational Plan, can receive Diagnostic Services from GTSS.
Volunteer State Health Plan is a Chattanooga, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Ann Retirement Center is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.